scholarly journals Evidence of growth hormone effect on plasma leptin in diet-induced obesity and diet-resistant rats

2019 ◽  
Vol 12 (5) ◽  
pp. 219-228
Author(s):  
Sutharinee Likitnukul ◽  
Sarinee Kalandakanond-Thongsong ◽  
Sumpun Thammacharoen

Abstract Background Plasma leptin is regulated by several factors, including growth hormone (GH), which influences the pathophysiology of obesity. Objective To demonstrate the short-term effect of GH on plasma leptin levels in 3 conditions in vivo with the different amount of body fat mass. Methods Adult male Wistar rats were fed with standard chow or hypercaloric diet (HC). The HC rats were demonstrated as HC-feeding obese (HC-O) and HC-feeding resistant (HC-R) rats. Then, they were treated with GH or saline for 3 days. Basal plasma leptin levels were measured at 24 and 32 h. For meal-induced condition, all rats were fed for 2 hand plasma leptin was measured. Further 16-h fasting period, plasma leptin, insulin, and insulin sensitivity indexes were determined. Results The short-term GH treatment decreased basal plasma leptin at 32 h after the first GH injection in HC-O rats. However, GH treatment had no effect on meal-induced plasma leptin in all rats. Furthermore, GH treatment attenuated fasting effect on plasma leptin in control and HC-R rats. The insulin resistance (IR) induced by the short-term GH treatment was demonstrated by higher fasting plasma insulin and the increased homeostasis model of IR in HC-R rats. Conclusions The study demonstrates the important role of greater fat mass in HC-O rats, which results in decreased basal plasma leptin after short-term GH treatment. For meal-induced condition, GH had no effect on plasma leptin in all rats. Interestingly, GH could attenuate fasting effect on plasma leptin in rats that have lower fat mass.

2008 ◽  
Vol 32 (3) ◽  
pp. 380-392 ◽  
Author(s):  
Scott A. Gahr ◽  
Roger L. Vallejo ◽  
Gregory M. Weber ◽  
Brian S. Shepherd ◽  
Jeffrey T. Silverstein ◽  
...  

Although studies have established that exogenous growth hormone (GH) treatment stimulates growth in fish, its effects on target tissue gene expression are not well characterized. We assessed the effects of Posilac (Monsanto, St. Louis, MO), a recombinant bovine GH, on tissue transcript levels in rainbow trout selected from two high-growth rate and two low-growth rate families. Transcript abundance was measured in liver and muscle with the Genome Research in Atlantic Salmon Project (GRASP) 16K cDNA microarray. A selection of the genes identified as altered by the microarray and transcripts for insulin-like growth factors, growth hormone receptors (GHRs), and myostatins were measured by real-time PCR in the liver, muscle, brain, kidney, intestine, stomach, gill, and heart. In general, transcripts identified as differentially regulated in the muscle on the microarray showed similar directional changes of expression in the other nonhepatic tissues. A total of 114 and 66 transcripts were identified by microarray as differentially expressed with GH treatment across growth rate for muscle and liver, respectively. The largest proportion of these transcripts represented novel transcripts, followed by immune and metabolism-related genes. We have identified a number of genes related to lipid metabolism, supporting a modulation in lipid metabolism following GH treatment. Most notable among the growth-axis genes measured by real-time PCR were increases in GHR1 and -2 transcripts in liver and muscle. Our results indicate that short-term GH treatment activates the immune system, shifts the metabolic sectors, and modulates growth-regulating genes.


1994 ◽  
Vol 266 (6) ◽  
pp. E840-E844 ◽  
Author(s):  
J. J. Zachwieja ◽  
D. M. Bier ◽  
K. E. Yarasheski

Evidence suggests that the albumin gene contains a growth hormone (GH) responsive element. Our purpose was to determine if GH administration to older men increases the rate of albumin synthesis and whether this is related to the increase in nitrogen retention observed during short-term recombinant human GH (rhGH) administration. Five older men (60-75 yr) received daily injections (40 micrograms/kg) of rhGH for 2 wk, whereas four others received daily injections (10 micrograms/kg) for 4 wk. In both the 2- and 4-wk recipients, rhGH administration increased (P < 0.05) fasting plasma insulin-like growth factor I levels and reduced (P < 0.05) 24-h urinary nitrogen excretion. However, during an overnight fast, the fractional rate of albumin synthesis determined by the in vivo rate of incorporation of intravenously infused L-[1-13C]leucine into plasma albumin was unchanged after 2 or 4 wk of treatment. The average plasma albumin fractional synthetic rate was 8.6 +/- 0.6%/day before and 9.4 +/- 0.7%/day after rhGH treatment (P = 0.12). We conclude that short-term rhGH administration and the subsequent increase in urinary nitrogen retention does not result in an increase in the rate of plasma albumin synthesis in older men.


1998 ◽  
Vol 6 (3-4) ◽  
pp. 317-323 ◽  
Author(s):  
Valéria De Mello-Coelho ◽  
Wilson Savino ◽  
Marie-Catherine Postel-Vinay ◽  
Mireille Dardenne

Intrathymic T-cell differentiation is under the control of the thymic microenvironment, which acts on maturing thymocytes via membrane as well as soluble products. Increasing data show that this process can be modulated by classical hormones, as exemplified herein by prolactin (PRL) and growth hormone (GH), largely secreted by the pituitary gland.Both PRL and GH stimulate the secretion of thymulin, a thymic hormone produced by thymic epithelial cells. Conversely, low levels of circulating thymulin parallel hypopituitary states. Interestingly, the enhancing effects of GH on thymulin seem to be mediated by insulinlike growth factor (IGF-1) since they can be abrogated with anti-IGF-1 or anti-IGF-l-receptor antibodies. The influence of PRL and GH on the thymic epithelium is pleiotropic: PRL enhancesin vivothe expression of high-molecular-weight cytokeratins and stimulatesin vitroTEC proliferation, an effect that is shared by GH and IGF-1.Differentiating T cells are also targets for the intrathymic action of PRL and GH.In vivoinoculation of a rat pituitary cell line into old rats results in restoration of the thymus, including differentiation of CD4-CD8-thymocytes into CD4+CD8+cells. Furthermore, PRL may regulate the maintenance of thymocyte viability during the double-positive stage of thymocyte differentiation.Injections of GH into aging mice increase total thymocyte numbers and the percentage of CD3-bearing cells, as well as the Concanavalin-A mitogenic response and IL-6 production by thymocytes. Interestingly, similar findings are observed in animals treated with IGF-1. Lastly, the thymic hypoplasia observed in dwarf mice can be reversed with GH treatment.In keeping with the data summarized earlier is the detection of receptors for PRL and GH on both thymocytes and thymic epithelial cells. Importantly, recent studies indicate that both cell types can produce PRL and GH intrathymically. Similarly, production of IGF-1 and expression of a corresponding receptor has also been demonstrated.In conclusion, these data strongly indicate that the thymus is physiologically under control of pituitary hormones PRL and GH. In addition to the classical endocrine pathway, paracrine and autocrine circuits are probably implicated in such control.


2002 ◽  
Vol 17 (2) ◽  
pp. 260-264 ◽  
Author(s):  
Pedro Iglesias ◽  
Juan José Díez ◽  
Ma José Fernández‐Reyes ◽  
Mc Auxiliadore Bajo ◽  
Abelardo Aguilera ◽  
...  

2009 ◽  
Vol 70 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Francisco J. A. de Paula ◽  
Miburge B. Góis-Júnior ◽  
Manuel H. Aguiar-Oliveira ◽  
Francisco de A. Pereira ◽  
Carla R. P. Oliveira ◽  
...  

1999 ◽  
Vol 50 (2) ◽  
pp. 163 ◽  
Author(s):  
E. Payne

Fatty acid (FA) synthesis was studied in lambs in vivo using the incorporation of tritium from tritiated water into FA under a number of experimental conditions. Expt 1 investigated the use of a high dose of tritiated water, with slaughter of the sheep after 4 h, and showed that sampling of tail fat was sucient as an index of the activity in carcass fat. Calculations of FA synthesised demonstrated the relative amounts contributed by carcass and offal. Extrapolation to a time of 24 h, assuming linearity of incorporation of tritium with time, gave results that were similar to what would be expected from the gains in body weight. Restriction of feed intake reduced the amount of FA synthesis. Expt 2 demonstrated that incorporation of tritium into FA was almost linear over 24 h after an initial delay (mixing time) and there was probably no redistribution of tritiated FA between tissues. The increased time for incorporation had 3 major advantages: the dose of tritiated water could be reduced to more manageable levels, the error due to mixing time was reduced, and the measurement of synthesis was integrated over 24 h. Expt 3 showed that increasing feed intake above 24 g/kg liveweight, which was close to maintenance, resulted in progressive increases in FA synthesis, measured by the technique of Expt 2 over 24 h. Incorporation of tritium into FA and non-saponifiable lipids, including cholesterol, in liver increased with feed intake in a sigmoid curve, with a maximum rate of change around an intake of 30 g/kg. This reflected the release of FA via lipoproteins into the circulation. The specific activity of the FA in the liver was similar to that of the ruminal FA and suggested that there was no actual synthesis in the liver. Expt 4 investigated the effects of growth hormone (GH), oestradiol, andff Triton WR1339 administration to lambs on FA synthesis following short-term administration of GH at 0·3 mg/lamb·day, oestradiol (120 µg on Day 1 and 3), or Triton WR1399. Growth hormone caused a significant reduction in FA synthesis/g FA (P < 0·05) and in FA synthesis/106 cells in subcutaneous fat (P < 0·01) after 4 days of administration. There was a reduction in cell diameter and number of fat cells/g FA (P < 0·05). Oestradiol showed a tendency to cause increased FA synthesis; there was a significant effect of treatment (P < 0·01) in omental fat. FA synthesis was significantly increased in the group of lambs given oestradiol by comparison with the group given GH (P < 0·01), whereas Triton WR1399 had no effect on FA synthesis in adipose tissue, substantiating that liver and plasma lipoproteins contribute only low amounts of FA to subcutaneous fat. Expt 5 further investigated the effects of administration of GH for 1 or 4 days to lambs on high-grain pellets consumed at high intakes (57 g/kg liveweight). GH had no effect, irrespective of how the results were expressed, but rates of FA synthesis were >10-fold higher than those in Expt 4. In both trials, plasma levels of GH were raised and plasma levels of insulin-like growth factor-1 indicated that GH was active. These results showed that FA synthesis can be measured in vivo in lambs effectively, and the method should be of more practical use than alternative methods in studies of agents affecting the level of carcass fat. The effects of GH were not as marked as those found in previous studies in pigs because of the short-term administration of GH, but even so, the excess intake of high-grain pellets appeared to prevent any effect of GH.


2010 ◽  
Vol 06 (01) ◽  
pp. 63
Author(s):  
Michelle L Klein ◽  
Robert Rapaport ◽  
◽  

Short-term studies of children born small for gestational age (SGA) who do not adequately catch up have shown that growth hormone (GH) treatment over a range of doses is both safe and effective at increasing growth velocity and height standard deviation (SD). Long-term studies have shown an improvement in adult height compared with untreated controls. Predictors of growth response include height and weight at start of GH treatment, pre-treatment growth velocity, target height, and pre-pubertal years treated with GH. Height prediction models are being developed to help maximize GH treatment response. While some short-term studies of GH treatment in SGA children have shown abnormalities in carbohydrate metabolism, long-term studies have demonstrated that these changes were transient. GH treatment has been shown to be safe and effective in increasing adult height of children born SGA. Follow-up is needed for assessment of the long-term effects of GH treatment.


Sign in / Sign up

Export Citation Format

Share Document